# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Wells Fargo analyst Chris Carey maintains Clorox (NYSE:CLX) with a Underweight and lowers the price target from $140 to $135.
Barclays analyst Lauren Lieberman maintains Clorox (NYSE:CLX) with a Underweight and lowers the price target from $136 to $132.
Citigroup analyst Wendy Nicholson maintains Clorox (NYSE:CLX) with a Neutral and lowers the price target from $155 to $150.
UBS analyst Peter Grom maintains Clorox (NYSE:CLX) with a Neutral and lowers the price target from $164 to $159.
JP Morgan analyst Andrea Teixeira maintains Clorox (NYSE:CLX) with a Neutral and lowers the price target from $159 to $158.
Evercore ISI Group analyst Javier Escalante maintains Clorox (NYSE:CLX) with a Underperform and lowers the price target from...
Clorox (NYSE:CLX) reported quarterly earnings of $1.71 per share which beat the analyst consensus estimate of $1.37 by 24.82 pe...
Investor apprehension grips Wall Street with major indices showing midday losses on Tuesday in New York trading, ahead of the F...